UCSF

Tagged: Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG)

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Sali elected to National Academy of Sciences

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

Behind enemy lines

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

UCSF School of Pharmacy leads in NIH funding for 38th year

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Taking a bite out of the proteome with PhaNGS

If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

Update from the Dean – March 2018

A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut drug discovery time; Computational approaches target dopamine receptors; Researchers expose industry manipulation of science by sugar industry; Women in science; Bioengineering devices to treat glaucoma, diabetes, kidney disease; Campus activism on DACA; A helping hand to Puerto Rico, Basic science scholarship for women in developing nations; A decade of science camp; Honors and awards; 2017 Distinguished Alumnus of the Year; 2018 Mary Anne Koda-Kimble Seed Award for Innovation; 2018 Byers Award in Basic Science; Chan Zuckerberg Biohub Investigators; New faculty; Remembering C.C. Wang; UCSF fundraising campaign; Alumni Weekend 2018.

Babbitt named a Fellow of the International Society for Computational Biology

Babbitt's election as a 2018 ISCB fellow highlights her contributions to the fields of computational biology and bioinformatics.

Unmasking a cellular hallmark of cancer

Scientists identify a signature of cancers caused by mutant RAS that may lead to precise therapies.

Computer models speed UCSF scientists toward psychiatric drug discoveries

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia. There are five types of dopamine receptors, and psychiatric drugs usually affect multiple receptors at once, often producing debilitating or even dangerous side effects.

Pages